If you are on transdermal HRT: No changes needed
Because GLP-1 medications can improve blood sugar, appetite, insulin sensitivity, and weight, researchers are studying whether the drugs may also improve some of the metabolic and hormone patterns that drive PMOS
Eligibility is a clinical judgment built from body mass index thresholds described in regulatory labeling, the presence or absence of weight-related health conditions, a screen for contraindications, and an assessment of whether medication fits a patients broader health picture
The active ingredient, semaglutide, works by mimicking the action of naturally occurring GLP-1, a hormone released by the intestine in response to food intake
In vitamin-related studies, the metabolic pathways of vitamin A and vitamin C are significantly alterations (138)
It is republished with permission.